Dmitry Bolotov
International Sales Director
Pharmasyntez JSC
Moscow, Russia
1 profile visit
International Sales Director in pharmaceuticals, with grate expertise in regulatory affairs for medicines and medical devices
My organisation
Pharmasyntez is one of Russia’s leading biopharmaceutical companies, specializing in the development, manufacture, and supply of socially important medicines. Established in 1997, the company has matured into a major player in hospital drugs, antitubercular, antineoplastic, and antiretroviral therapy, as well as antibiotics. Key Capabilities • Portfolio: Over 300 drug products and more than 60 active pharmaceutical substances. • Dosage forms: Tablets, capsules, granules, infusion solutions, sterile powders, injectables, etc. • Research & Innovation: Pharmasyntez invests significantly in R&D for original medicines, technology transfer, and generics. Manufacturing Footprint The company operates five high-tech manufacturing plants in: • Irkutsk • Ussuriysk • Bratsk • St. Petersburg (“Pharmasyntez-Nord”) • Tyumen (“Pharmasyntez-Tyumen”) These plants conform to GMP standards, employ modern production and analytical equipment, and collectively produce tens of millions of packs annually. Therapeutic Focus & Product Highlights • Oncology / Antineoplastic drugs; immunology; antiviral and antiretroviral therapies. • Hormonal drugs and contraceptives, including recent launches in hormonal gel (estradiol) for menopause symptom relief. • Antitubercular medicines are a core specialty; also active in treatments for diabetes, HIV/AIDS, and other socially critical diseases. Regulation, Quality, and Standards • All plants meet Russian GMP (Good Manufacturing Practice) and use state-of-the-art equipment. • Many products are part of the Russian Ministry of Health’s “Vital and Essential Drugs” list. Business, Partnerships & Strategy • Strong distributor network: more than 50 traders across Russia and the CIS. • Focus on import substitution: replacing imported products with domestically produced equivalents. • Investments: yearly investments into innovative medicines and expanded capacity. Workforce & Social Responsibility • Employs over 5,000 qualified specialists. • Provides training, education support, good working conditions, employee wellness programs. Mission & Values Pharmasyntez is committed to producing high-quality, effective medicines that are accessible to patients and healthcare institutions. The company emphasizes professionalism, legal compliance, and sustainable long-term partnerships—both domestically and internationally.